IRulya Therapeutics Inc. vs Relmada Therapeutics, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- IRulya Therapeutics Inc. and Relmada Therapeutics, Inc. are worth about the same: $343 M and $337 M (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Oct 20, 2026 for Relmada Therapeutics, Inc.).
- Both made a net loss: $84 M for IRulya Therapeutics Inc. and $57 M for Relmada Therapeutics, Inc.
- IRulya Therapeutics Inc. employs more people: 55 against 10 at Relmada Therapeutics, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Side by side
| Measure | IRulya Therapeutics Inc. IRLA · #14,196 in the world | Relmada Therapeutics, Inc. RLMD · #14,268 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2004 |
| Size | ||
| Market cap | $343 M | $337 M |
| Net income | $-84 M | $-57 M▲ best |
| Employees | 55 | 10 |
| Valuation | ||
| Price to book | — | 3.9× |
| Free cash flow yield | -12.2%▲ best | -62.2% |
| Profitability | ||
| Return on equity | — | -94.1% |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, IRulya Therapeutics Inc. or Relmada Therapeutics, Inc.?
IRulya Therapeutics Inc. and Relmada Therapeutics, Inc. are worth about the same: $343 M and $337 M (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Oct 20, 2026 for Relmada Therapeutics, Inc.).
Which makes more money, IRulya Therapeutics Inc. or Relmada Therapeutics, Inc.?
Both made a net loss: $84 M for IRulya Therapeutics Inc. and $57 M for Relmada Therapeutics, Inc.
Which has more employees, IRulya Therapeutics Inc. or Relmada Therapeutics, Inc.?
IRulya Therapeutics Inc. employs more people: 55 against 10 at Relmada Therapeutics, Inc.